Addressing unique evidence needs and solutions for approval and market access of rare disease treatments
Announcing the Spring Issue of The Evidence Forum
Evidera's biannual publication addresses the scientific, strategic, and operational challenges of today's health care environment, providing a forum for the exchange of thoughts and ideas focused on evidence and value. This issue specifically focuses on the increasing importance and effect of rare diseases in the drug development paradigm and the changing needs for approval and access.
The Evidence Forum
In this issue:
Read now
Sign up for future content
30+ Years of Experience
Real-World Evidence • Patient-Centered Research
Evidence Synthesis, Modeling & Communication • Market Access
Interventional Studies • Pragmatic Studies • Medical Writing

Evidera logo
U.S. +1 301 654 9729       
EUR +44 (0) 208 576 5000

Corporate Offices
Boston | Budapest | London | Montreal | Paris | Research Triangle Park | San Francisco | Seattle | Washington, DC





This email was sent on behalf of the sponsor by HealthEconomics.Com, 1327 Walnut, Jacksonville, FL, 32206.
If you don't wish to receive further Industry Leaders News Updates from us, you may immediately unsubscribe from this list here, or send your request in writing to the address above.
Read more about our privacy policy here. You may also request a copy in writing using the address above.



To ensure you continue to receive emails from HealthEconomics.Com, please click here.